Stephen Willey
Stock Analyst at Stifel
(3.37)
# 1,008
Out of 4,983 analysts
120
Total ratings
40.86%
Success rate
6.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stephen Willey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XFOR X4 Pharmaceuticals | Maintains: Buy | $30 → $9 | $2.99 | +201.00% | 3 | Aug 29, 2025 | |
| INSM Insmed | Maintains: Buy | $121 → $145 | $143.14 | +1.30% | 7 | Aug 14, 2025 | |
| NKTX Nkarta | Maintains: Buy | $14 → $12 | $1.97 | +509.14% | 4 | Aug 14, 2025 | |
| ABCL AbCellera Biologics | Maintains: Buy | $8 → $7 | $4.35 | +60.92% | 6 | Aug 8, 2025 | |
| EXEL Exelixis | Maintains: Hold | $38 → $41 | $39.01 | +5.10% | 19 | Jul 29, 2025 | |
| CELC Celcuity | Reinstates: Buy | $30 | $55.07 | -45.52% | 1 | Jul 1, 2025 | |
| CBIO Crescent Biopharma | Initiates: Buy | $28 | $12.22 | +129.13% | 1 | Jun 25, 2025 | |
| INCY Incyte | Upgrades: Buy | $75 → $107 | $83.14 | +28.70% | 6 | Jun 16, 2025 | |
| MGNX MacroGenics | Maintains: Hold | $6 → $5 | $1.56 | +220.51% | 3 | May 14, 2025 | |
| BOLT Bolt Biotherapeutics | Maintains: Hold | $25 → $20 | $5.30 | +277.36% | 4 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $35 | $8.67 | +303.69% | 5 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $5 | $1.60 | +212.50% | 5 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $1.27 | +214.96% | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $28 | $15.93 | +75.77% | 6 | Oct 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $11.38 | +313.01% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $0.74 | +440.61% | 7 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $34 → $3 | $2.11 | +42.52% | 3 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $1.38 | +189.86% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $53 → $62 | $36.08 | +71.84% | 5 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $3.69 | +143.90% | 1 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.61 | +645.34% | 1 | Nov 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $228 → $288 | $2.28 | +12,531.58% | 4 | Jun 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $21 | $1.88 | +1,017.02% | 2 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $10 → $4 | $1.12 | +257.14% | 7 | Jul 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $123 | $461.14 | -73.33% | 3 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $48 → $47 | $61.10 | -23.08% | 2 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $102 → $109 | $53.14 | +105.12% | 3 | Aug 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Terminates: Hold | n/a | $19.55 | - | 2 | Jun 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $23 | $7.81 | +194.49% | 5 | Feb 7, 2018 |
X4 Pharmaceuticals
Aug 29, 2025
Maintains: Buy
Price Target: $30 → $9
Current: $2.99
Upside: +201.00%
Insmed
Aug 14, 2025
Maintains: Buy
Price Target: $121 → $145
Current: $143.14
Upside: +1.30%
Nkarta
Aug 14, 2025
Maintains: Buy
Price Target: $14 → $12
Current: $1.97
Upside: +509.14%
AbCellera Biologics
Aug 8, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $4.35
Upside: +60.92%
Exelixis
Jul 29, 2025
Maintains: Hold
Price Target: $38 → $41
Current: $39.01
Upside: +5.10%
Celcuity
Jul 1, 2025
Reinstates: Buy
Price Target: $30
Current: $55.07
Upside: -45.52%
Crescent Biopharma
Jun 25, 2025
Initiates: Buy
Price Target: $28
Current: $12.22
Upside: +129.13%
Incyte
Jun 16, 2025
Upgrades: Buy
Price Target: $75 → $107
Current: $83.14
Upside: +28.70%
MacroGenics
May 14, 2025
Maintains: Hold
Price Target: $6 → $5
Current: $1.56
Upside: +220.51%
Bolt Biotherapeutics
May 13, 2025
Maintains: Hold
Price Target: $25 → $20
Current: $5.30
Upside: +277.36%
Apr 9, 2025
Maintains: Buy
Price Target: $36 → $35
Current: $8.67
Upside: +303.69%
Mar 21, 2025
Maintains: Buy
Price Target: $12 → $5
Current: $1.60
Upside: +212.50%
Feb 27, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.27
Upside: +214.96%
Oct 28, 2024
Maintains: Buy
Price Target: $21 → $28
Current: $15.93
Upside: +75.77%
Oct 8, 2024
Initiates: Buy
Price Target: $47
Current: $11.38
Upside: +313.01%
Aug 20, 2024
Maintains: Buy
Price Target: $8 → $4
Current: $0.74
Upside: +440.61%
Jul 9, 2024
Downgrades: Hold
Price Target: $34 → $3
Current: $2.11
Upside: +42.52%
Dec 19, 2023
Maintains: Buy
Price Target: $3 → $4
Current: $1.38
Upside: +189.86%
Dec 18, 2023
Maintains: Buy
Price Target: $53 → $62
Current: $36.08
Upside: +71.84%
Jan 27, 2023
Initiates: Buy
Price Target: $9
Current: $3.69
Upside: +143.90%
Nov 28, 2022
Initiates: Buy
Price Target: $12
Current: $1.61
Upside: +645.34%
Jun 26, 2020
Downgrades: Hold
Price Target: $228 → $288
Current: $2.28
Upside: +12,531.58%
Mar 17, 2020
Maintains: Buy
Price Target: $22 → $21
Current: $1.88
Upside: +1,017.02%
Jul 29, 2019
Downgrades: Hold
Price Target: $10 → $4
Current: $1.12
Upside: +257.14%
Aug 13, 2018
Maintains: Buy
Price Target: $125 → $123
Current: $461.14
Upside: -73.33%
Aug 8, 2018
Maintains: Hold
Price Target: $48 → $47
Current: $61.10
Upside: -23.08%
Aug 3, 2018
Maintains: Buy
Price Target: $102 → $109
Current: $53.14
Upside: +105.12%
Jun 25, 2018
Terminates: Hold
Price Target: n/a
Current: $19.55
Upside: -
Feb 7, 2018
Maintains: Buy
Price Target: $20 → $23
Current: $7.81
Upside: +194.49%